Hemoglobin Increase Is Associated with Improved Health-Related Quality of Life in Patients with Cancer Not Receiving Chemotherapy

This publication has 19 references indexed in Scilit:

• A dose- and schedule-finding study of darbepoetin alpha for the treatment of chronic anaemia of cancer
  British Journal of Cancer, 2003
• Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Darbepoetin Alfa in Lung Cancer Patients Receiving Chemotherapy
  JNCI Journal of the National Cancer Institute, 2002
• Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy
  British Journal of Cancer, 2002
• Applications of darbepoietin-α, a novel erythropoiesis-stimulating protein, in oncology
  Current Opinion in Hematology, 2002
• Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy
  British Journal of Cancer, 2001
• Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing
  Journal of Clinical Oncology, 2001
• Improvement in haemoglobin levels improves health-related quality of life (HRQOL) of anaemic cancer patients
  European Journal Of Cancer, 2001
• Anaemia in cancer: pathophysiology and treatment
  Cancer Treatment Reviews, 2000
• Erythropoietin for anaemia in cancer patients
  European Journal Of Cancer, 1993
• Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy
  JNCI Journal of the National Cancer Institute, 1993